These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Endothelial progenitor cells and rheumatic disease modifying therapy. Lo Gullo A; Aragona CO; Scuruchi M; Versace AG; Saitta A; Imbalzano E; Loddo S; Campo GM; Mandraffino G Vascul Pharmacol; 2018 Sep; 108():8-14. PubMed ID: 29842927 [TBL] [Abstract][Full Text] [Related]
27. Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: study using the Spanish registry of adverse events of biological therapies in rheumatic diseases. Hernández MV; Sanmartí R; Cañete JD; Descalzo MA; Alsina M; Carmona L; Gomez-Reino JJ; Arthritis Care Res (Hoboken); 2013 Dec; 65(12):2024-31. PubMed ID: 23926075 [TBL] [Abstract][Full Text] [Related]
29. Putative effects of potentially anti-angiogenic drugs in rheumatic diseases. Maruotti N; Cantatore FP; Ribatti D Eur J Clin Pharmacol; 2014 Feb; 70(2):135-40. PubMed ID: 24196651 [TBL] [Abstract][Full Text] [Related]
30. Tocilizumab: a novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases. Alten R; Maleitzke T Ann Med; 2013 Jun; 45(4):357-63. PubMed ID: 23650978 [TBL] [Abstract][Full Text] [Related]
31. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease. Cepeda EJ; Williams FM; Ishimori ML; Weisman MH; Reveille JD Ann Rheum Dis; 2008 May; 67(5):710-2. PubMed ID: 18079191 [TBL] [Abstract][Full Text] [Related]
32. [Therapy of dyslipidemia in rheumatic diseases]. Vordenbäumen S; Schinner S; Halle M; Fischer-Betz R; Schneider M Z Rheumatol; 2010 Oct; 69(8):689-92, 694-5. PubMed ID: 20862479 [TBL] [Abstract][Full Text] [Related]
33. Chemokines in rheumatic diseases: pathogenic role and therapeutic implications. Miyabe Y; Lian J; Miyabe C; Luster AD Nat Rev Rheumatol; 2019 Dec; 15(12):731-746. PubMed ID: 31705045 [TBL] [Abstract][Full Text] [Related]
34. [Institute of Rheumatology and progress of antirheumatic therapy]. Sigidin IaA Vestn Ross Akad Med Nauk; 1998; (12):7-9. PubMed ID: 9987950 [TBL] [Abstract][Full Text] [Related]